ATP6AP1-DT: A Potential Drug Target and Biomarker (G158960)

Target Name: ATP6AP1-DT

NCBI ID: G158960

ATP6AP1-DT

Other Name(s): CH17-340M24.3 | ATP6AP1 divergent transcript

ATP6AP1-DT: A Potential Drug Target and Biomarker

ATP6AP1-DT, also known as CH17-340M24.3, is a protein that is expressed in various tissues and cells in the body. It is a key regulator of the protein ATP6AP1, which is involved in a variety of cellular processes. ATP6AP1-DT has been identified as a potential drug target and may be useful in the development of new treatments for various diseases.

The protein ATP6AP1 is a key regulator of the intracellular signaling pathway known as the tiered GTPase-coupled signaling (TGCS) pathway. This pathway is involved in the regulation of various cellular processes, including cell growth, differentiation, and survival. ATP6AP1 is a critical protein for the TGCS pathway, as it plays a role in the regulation of the activity of several downstream effectors, including the protein Pyh1.

Pyh1 is a protein that is involved in the regulation of cell adhesion and the formation of tight junctions, which are specialized barriers that separate cells from their surrounding environment. The TGCS pathway is involved in the regulation of Pyh1 activity, and studies have suggested that ATP6AP1 may be involved in the regulation of Pyh1 activity.

In addition to its role in the TGCS pathway, ATP6AP1 is also involved in the regulation of various cellular processes that are critical for cell survival. For example, ATP6AP1 has been shown to play a role in the regulation of cell division and apoptosis, as well as in the regulation of cell signaling pathways that are involved in cell growth and differentiation.

Given its involvement in the regulation of multiple cellular processes, ATP6AP1 has been identified as a potential drug target. Studies have shown that inhibiting the activity of ATP6AP1 has the potential to treat a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

In addition to its potential as a drug target, ATP6AP1 has also been identified as a potential biomarker. The TGCS pathway is involved in the regulation of various cellular processes that are critical for cell survival, and changes in the activity of this pathway have been associated with the development of a variety of diseases. Therefore, measuring the activity of ATP6AP1, as well as other TGCS pathway proteins, may be a useful diagnostic tool for the diagnosis of certain diseases.

In conclusion, ATP6AP1-DT is a protein that is involved in the regulation of multiple cellular processes and has been identified as a potential drug target and biomarker. Further research is needed to fully understand the role of ATP6AP1 in cellular processes and its potential as a drug and biomarker.

Protein Name: ATP6AP1 Divergent Transcript

The "ATP6AP1-DT Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ATP6AP1-DT comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets